ARCHIVES

NCI Programs: Researchers Take “Director’s Challenge” to Develop Molecular Profiles of Tumors

This article is from The Cancer Letter archive.

Vol. 25 No. 47 | December 10, 1999

Download PDF Visit The Full Archive

Related Articles

In Brief: House Cuts NCI Rescission To $7.73 Million; Weinhuse, Ultmann New ACCR, ASCO Presidents

May 8, 1981

Wallen Pleads Guilty To Lesser Charges, To Pay $20,000 to CALGB, FDA

August 31, 1984

FDA Vs. NCI: Nothing Has Changed; Chabner “Frustrated” By Flutamide Delay

October 21, 1988

LeMaistre Blasts “Death Merchants’ In tobacco Industry

May 5, 1989

IND-Exempt Trials May Need Special Review, HCFA Says.

September 29, 2000

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

July 28, 2000